These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7784974)

  • 1. [The venous occlusion test in assessing the fibrinolytic activity of the vascular endothelium in lupus nephritis patients].
    Bobkova IN; Poliantseva LR; Tareeva IE; Andreenko GV; Podorol'skaia LV
    Ter Arkh; 1995; 67(4):42-5. PubMed ID: 7784974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The functional activity of plasminogen activators in the blood plasma and urine of patients with lupus nephritis].
    Poliantseva LR; Tareeva IE; Bobkova IN; Podorol'skaia LV; Andreenko GV
    Ter Arkh; 1994; 66(6):39-41. PubMed ID: 7940365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tissue-type plasminogen activator in patients with lupus nephritis].
    Poliantseva LG; Bobkova IN; Tareeva IE; Podorol'skaia LV; Andreenko GV
    Ter Arkh; 1995; 67(5):17-9. PubMed ID: 7638768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical importance of determining the von Willebrand factor in patients with lupus nephritis].
    Bobkova IN; Poliantseva LR; Tareeva IE; Kozlovskaia LV
    Ter Arkh; 1995; 67(5):14-6. PubMed ID: 7638767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
    Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The criteria for indication of plasma exchange on lupus nephritis].
    Wakai S
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):703-13. PubMed ID: 2214318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].
    Smyr KV; Shcherbak AV; Kozlovskaia LV; Sokolova IA; Bobkova IN; Podorol'skaia LV
    Ter Arkh; 2010; 82(1):47-51. PubMed ID: 20364701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary fibronectin as an indicator of kidney fibrosis in nephritis].
    Kozlovskaia LV; Bobkova IN; Varshavskiĭ VA; Proskurneva EP; Miroshnichenko NG; Chebotareva NV; Mukhin NA
    Ter Arkh; 1999; 71(6):34-8. PubMed ID: 10420453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis].
    Kubicka A; Libura M; Sacha T; Swadźba J; Undas A; Wandzilak M
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):116-9. PubMed ID: 8361905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
    Stalder M; Hauert J; Bachmann F
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis.
    Yao G; Liu ZH; Zheng C; Zhang X; Chen H; Zeng C; Li LS
    Rheumatology (Oxford); 2008 Apr; 47(4):432-6. PubMed ID: 18292121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic mechanisms of lupus nephritis progression].
    Tareeva IE; Shvetsov MIu; Kutyrina IM; Gerasimenko OI
    Ter Arkh; 1998; 70(6):11-4. PubMed ID: 9695215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
    Du XH; Glas-Greenwalt P; Kant KS; Allen CM; Hayes S; Pollak VE
    Clin Nephrol; 1985 Oct; 24(4):186-91. PubMed ID: 3933871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increase of leg fibrinolytic potential after reduction of hydrostatic stimulus.
    Keber D
    Thromb Haemost; 1983 Oct; 50(3):731-4. PubMed ID: 6685927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis.
    Awada H; Barlowatz-Meimon G; Dougados M; Maisonneuve P; Sultan Y; Amor B
    J Lab Clin Med; 1988 Feb; 111(2):229-36. PubMed ID: 3123585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic activity in gastric venous blood. A comparison between normal and diseased stomachs.
    O'Brien TE; Hadley H; Irving MH
    Gastroenterology; 1979 Mar; 76(3):509-14. PubMed ID: 155020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
    Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.